Together, the expression of adhesion or BM retention–related markers (CXCL12, DCN, and TGM2) is reduced or lost at advanced stages of multiple myeloma, which could enhance dissemination and reduce retention in the BM microenvironment. The gene discussed is DCN; the disease is plasma cell myeloma.